Fennec Pharmaceuticals (FENC) Profit After Tax (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -650.31% |
| Sep 30, 2025 | 79.76% |
| Jun 30, 2025 | -170.56% |
| Mar 31, 2025 | 41.31% |
| Dec 31, 2024 | 65.39% |
| Sep 30, 2024 | -3.28% |
| Jun 30, 2024 | -143.26% |
| Mar 31, 2024 | 578.64% |
| Dec 31, 2023 | -43.65% |
| Sep 30, 2023 | 65.71% |
| Jun 30, 2023 | 10.05% |
| Mar 31, 2023 | 10.02% |
| Dec 31, 2022 | 15.86% |
| Sep 30, 2022 | -58.08% |
| Jun 30, 2022 | -40.67% |
| Mar 31, 2022 | 15.53% |
| Dec 31, 2021 | -0.97% |
| Sep 30, 2021 | -7.61% |
| Jun 30, 2021 | 20.24% |
| Mar 31, 2021 | -47.34% |
| Dec 31, 2020 | 42.90% |
| Sep 30, 2020 | -20.90% |
| Jun 30, 2020 | -27.05% |
| Mar 31, 2020 | -6.03% |
| Dec 31, 2019 | -99.89% |
| Sep 30, 2019 | 61.88% |
| Jun 30, 2019 | -79.09% |
| Mar 31, 2019 | 12.00% |
| Dec 31, 2018 | -8.55% |
| Sep 30, 2018 | -6.26% |
| Jun 30, 2018 | -64.99% |
| Mar 31, 2018 | 31.53% |
| Dec 31, 2017 | 2.64% |
| Sep 30, 2017 | -47.18% |
| Jun 30, 2017 | -98.26% |
| Mar 31, 2017 | 29.48% |
| Dec 31, 2016 | -127.69% |
| Sep 30, 2016 | 30.66% |
| Jun 30, 2016 | -72.38% |
| Mar 31, 2016 | 22.22% |
| Dec 31, 2015 | -339.02% |
| Sep 30, 2015 | 28.90% |
| Jun 30, 2015 | -197.74% |
| Mar 31, 2015 | -87.25% |
| Dec 31, 2014 | 265.26% |
| Sep 30, 2014 | 150.67% |
| Jun 30, 2014 | 76.52% |
| Mar 31, 2014 | -387.49% |
| Dec 31, 2013 | 162.91% |
| Sep 30, 2013 | -126.73% |
| Jun 30, 2013 | 260.83% |
| Mar 31, 2013 | 36.91% |
| Dec 31, 2012 | -752.23% |
| Sep 30, 2012 | -26.91% |
| Jun 30, 2012 | -122.17% |
| Mar 31, 2012 | -22.63% |
| Dec 31, 2011 | 211.61% |
| Sep 30, 2011 | -803.45% |
| Jun 30, 2011 | -107.45% |
| Mar 31, 2011 | 170.91% |
| Dec 31, 2010 | -488.67% |
| Sep 30, 2010 | 165.94% |